Pharma Talent 2030: Building Dual-Expertise Teams in Science and Digital
The pharmaceutical industry faces a structural talent gap that headcount alone cannot close. This article examines the rise of the dual-expert archetype — professionals fluent in both scientific and digital domains — maps four critical emerging roles, and presents a 2030 Skills Matrix with a practical framework for redesigning pharma competency models and learning academies.
The pharmaceutical industry faces a structural talent gap that headcount alone cannot close. This article examines the rise of the dual-expert archetype — professionals fluent in both scientific and digital domains — maps four critical emerging roles, and presents a 2030 Skills Matrix with a practical framework for redesigning pharma competency models and learning academies.
Organization Learning Labs
Research & Insights Division
